Vaccination to modulate atherosclerosis

Takayuki Kimura, Kevin Tse, Alessandro Sette, Klaus Ley

Research output: Contribution to journalArticlepeer-review

52 Scopus citations


Atherosclerosis is a chronic inflammatory disease of the artery wall. Adaptive immunity plays a key role in the pathogenesis of atherosclerosis. Recently, modulation of the immune response against atherosclerotic plaque antigen(s) has attracted attention as a potentially preventive and therapeutic approach. Here, we review a series of studies on immunization with various antigens targeting treatment and prevention of atherosclerosis. Atherosclerosis-related antigens include oxidized low-density lipoprotein (LDL), apolipoprotein B-100 (ApoB-100) and heat shock protein (HSP) 60/65. Accumulating evidence supports the idea that immunization with these antigenic proteins or peptides may reduce atherosclerosis. In this review, we discuss the current status of immunization studies and possible associated mechanisms of atheroprotection.

Original languageEnglish (US)
Pages (from-to)152-160
Number of pages9
Issue number3
StatePublished - May 1 2015
Externally publishedYes


  • Apolipoprotein B-100
  • Atherosclerosis
  • Heat shock protein 65
  • Immunization
  • Low-density lipoprotein

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Vaccination to modulate atherosclerosis'. Together they form a unique fingerprint.

Cite this